Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
2(11%)
Results Posted
25%(3 trials)

Phase Distribution

Ph phase_1
1
5%
Ph not_applicable
3
16%
Ph phase_3
3
16%
Ph phase_4
8
42%
Ph phase_2
4
21%

Phase Distribution

1

Early Stage

4

Mid Stage

11

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
1(5.3%)
Phase 2Efficacy & side effects
4(21.1%)
Phase 3Large-scale testing
3(15.8%)
Phase 4Post-market surveillance
8(42.1%)
N/ANon-phased studies
3(15.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

19

all time

Status Distribution
Active(2)
Completed(12)
Other(5)

Detailed Status

Completed12
unknown5
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.3%)
Phase 24 (21.1%)
Phase 33 (15.8%)
Phase 48 (42.1%)
N/A3 (15.8%)

Trials by Status

completed1263%
unknown526%
recruiting15%
active_not_recruiting15%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT05042505Not Applicable

Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation

Completed
NCT04323189Phase 4

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

Active Not Recruiting
NCT06187285Not Applicable

Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

Completed
NCT06329882Phase 1

Doxycycline in Type II Diabetes

Recruiting
NCT05579119Phase 4

SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)

Completed
NCT05972928Phase 2

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

Unknown
NCT04495881Phase 4

Sitagliptin for the Treatment of Type 2 Diabetes

Unknown
NCT05195944Phase 4

Semaglutide vs Sitagliptin

Unknown
NCT04801199Phase 3

Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus

Completed
NCT04916093Phase 4

Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes

Completed
NCT03959501Phase 4

Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy

Completed
NCT04448587Phase 2

Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease

Unknown
NCT04061473Not Applicable

Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion

Completed
NCT03717688Phase 4

The Effects of Neprilysin on Glucagon-like Peptide-1

Completed
NCT01376323Phase 2

A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

Completed
NCT03125694Phase 3

Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea

Completed
NCT01475461Phase 2

Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes

Completed
NCT02480465Phase 4

Efficacy and Safety of Lobeglitazone Versus Sitagliptin

Unknown
NCT01289990Phase 3

Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19